September 2015 Dividends

Equities continued to slide throughout September, with the worse loss coming from my one speculative non-dividend-paying growth stock, Valeant Pharmaceuticals International Inc. (TSE: VRX). You can read how the U.S. Democrats seek subpoena on drug price hikes on Valeant heart drugs Nitropress and Isuprel, which were increased by 212 per cent Read more